Antithyroid drug-induced agranulocytosis: Report of 13 cases

Chang Gung Medical Journal

Volumn 30, Issue 3, 2007, Pages 242-248

  Huang, Chung Huei ^a   Li, Kay Lun ^a   Wu, Jin Hou ^a,b   Wang, Po Nan ^a,b   Juang, Jyuhn Huarng ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Agranulocytosis; Antithyroid drugs; Graves' hyperthyroidism

Indexed keywords

ANTIBIOTIC AGENT; ANTITHYROID AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGRANULOCYTOSIS; CHILL; CLINICAL FEATURE; DISEASE DURATION; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; REVIEW; SORE THROAT;

ADULT; AGRANULOCYTOSIS; ANTITHYROID AGENTS; BACTERIAL INFECTIONS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED;

EID: 34547754410     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-48.
2. Steinman L. Immune therapy for autoimmune diseases. Science 2004;305:212-6.
3. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35.
4. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, Ridgway EC. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983;98:26-9.
5. Davies TF, Larsen PR. Thyrotoxicosis. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia: WB Saunders, 2003:374-421.
6. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17.
7. Li KL, Huang HS, Wang PW, Lin JD, Juang JH, Liu RT, Huang BY, Huang MJ. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis - report of 11 patients. Chang Gung Med J 1991;14:168-73.
8. Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, Chang SC, Hsieh WC. Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. QJM 1999;92:455-61.
9. Cooper DS, Daniels GH, Ridgeway EC. Agranulocytosis and dose of methimazole. Ann Intern Med 1984;101:283.
10. McGavack TH, Chevalley J. Untoward hematologic responses to the antithyroid compounds. Am J Med 1954;17:36-40.
11. Hou GL, Tsai CC. Oral manifestations of agranulocytosis associated with methimazole therapy. J Periodontol 1988;59:244-8.
12. Dai WX, Zhang JD, Zhan SW, Xu BZ, Jin H, Yao Y, Xin WC, Bai Y. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Endocr J 2002;49:29-33.
13. Nakashima T, Taurog A. Rapid conversion of carbimazole to methimazole in serum; evidence for an enzymatic mechanism. Clin Endocrinol (Oxf) 1979;10:637-48.
14. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 1984;58:868-72.
15. Toth EL, Mant MJ, Shivji S, Ginsberg J. Propylthiouracilinduced agranulocytosis: an unusual presentation and a possible mechanism. Am J Med 1988;85:725-7
16. Douer D, Eisenstein Z. Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient's serum. Eur J Haematol 1988;40:91-4.
17. Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 1986;64:363-73.
18. Salama A, Northoff H, Burkhardt H, Mueller-Eckhardt C. Carbimazole-induced immune haemolytic anaemia: role of drug-red blood cell complexes for immunization. Br J Haematol 1988;68:479-82.
19. Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, Murakami N, Niho Y. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch Intern Med 1993;153:509-14.
20. Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 1999;9:29-31.
21. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150:621-4.
22. Hanna FW, Lazarus JH, Scanlon MR Controversial aspects of thyroid disease. BMJ 1999;319:894-9.
23. Toft AD, Weetman AP. Screening for agranulocytosis in patients treated with antithyroid drugs. Clin Endocrinol (Oxf) 1998;49:271.